
CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.

Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.

The role of many in psychiatry has changed during the COVID-19 pandemic.

A pair of researchers present plans to improve collaboration with other professionals in ADHD.

Dr. David Goodman predicts some patients may improve their organizational skills during the pandemic.

Adults with ADHD may face a number of challenges during the ongoing pandemic.

The virtual conference will feature researchers from the US, Germany, Japan, and more.

A conversation on how associations between the chronic conditions have become better understood in 10 years.

Peter Lio, MD, discusses conventional therapeutic options for pruritus.

ADM Giroir, MD, discusses additional examples of efforts to optimize sickle cell care.

The US Assistant Secretary for Health provides a top-down, government-level perspective on how sickle cell care has advanced in recent years.

Peter Lio, MD, discusses the various underlying causes behind itch.

The TARGET-NASH study seeks to shed light on treatment for NASH and NAFLD.

Amputations have increased 30% among diabetic patients since the pandemic began.

There is concern over whether or not patients are adhering to their treatment during the pandemic.

Dr. Giorgino discusses how combining SGLT2 Inhibitors and GLP-1RA could be combined for treating type 2 diabetes.

Diabetic patients are more susceptible to severe COVID-19 outcomes.

Dr. Kausik Ray presents new data on inclisiran and bempedoic acid as cholesterol lowering medications.

A pediatric dermatologist discusses dupilumab for pediatric atopic dermatitis in addition to promising new therapies.

A uveitis specialist breaks down what occurs during the uveitis-dedicated event and comments on its importance.

A new IRIS registry analysis reports that many patients with geographic atrophy do not continue follow-up after initial visit or consultation.

Girish Hiremath, MD, MPH, discusses a need to more accurately and objectively assess pediatric compliance to eosinophilic esophagitis therapies.

The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.

Benjamin Noor, MD, discusses a recent study from ACG that demonstrated that EBTs are associated with improved parameters for weight loss and diabetes.

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

Brad Glick gives an overview of new and exciting trends in the field of dermatology.

Brad Glick, DO, FAAD, previews a few of the topics that will be discussed on Derm Discussions, HCPLive's new expert-led skin health podcast series.

The host of HCPLive's new derm podcast series discusses what to expect as well as the importance of multimedia medical news.

An expert offers 5 tips to physicians and patients on best practices for managing symptoms related to allergic asthma.

Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.